Get started
Author

Yee Elise Vong Kiat

Observed names: Elise KY Vong, Elise Kiat Yee Vong, Elise Vong
ORCID: 0000-0002-8870-1391
Observed ORCID: 0000-0002-8870-1391
OpenAlex ID: A5080419469
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship
2023 · Issam Raad, Ray Hachem, et al. · eLife · 17
Emerging bladder-sparing treatments for high risk non-muscle invasive bladder cancer
2025 · Clarissa M Gurbani, Yew-Lam Chong, et al. · Bladder Cancer · 7
Postacute Sequelae Following Omicron COVID-19 in Patients With Cancer
2026 · Liang En Wee, Muhammad Ismail Bin Abdul Malek, et al. · JAMA Network Open · 1
Lung cancer management during the COVID-19 pandemic: experience of a medical oncology unit at a tertiary hospital in Singapore
2020 · Elise KY Vong, Puey-Ling Chia, et al. · Journal of Cancer Metastasis and Treatment · 1
PDF
Editorial Comment to Impact of the coronavirus disease‐2019 pandemic on the number of patients undergoing radical nephroureterectomy and postoperative adjuvant systematic therapy for upper tract urothelial carcinomas in Japan: A multicenter retrospective study
2023 · Zhen Wei Choo, Jeffrey J. Leow, et al. · International Journal of Urology
Author response: International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship
2022 · Issam I Raad, Ray Hachem, et al. · eLife
PDF
22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome
2021 · Ray Y Hachem, Anne-Marie Chaftari, et al. · Open Forum Infectious Diseases
PDF
Novel Options in Metastatic and Non-surgically Curable Bladder Cancer
2018 · Elise Vong, Jens Samol · European Oncology & Haematology
Works count: 8
Citation count: 26
H-index: 2
I10-index: 1
Year
Topic
Type